The University of Oxford's Brazilian trial of its vaccine candidate will continue after the death of a volunteer, the university said on Wednesday, adding an independent review had revealed no safety concerns. Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter. ALSO READ | Leading Covid-19 vaccine trial resumes in Japan but not USThe regulator said testing of the vaccine would continue after the volunteer's death. Brazil has the second deadliest outbreak of coronavirus, with more than 154 000 killed by Covid-19, following only the United States. It is the third worst outbreak in terms of cases, with more than 5.2 million infected, after the United States and India.

Source: News 24 October 21, 2020 17:26 UTC